Editors:
A practical case study guide for all clinicians involved in the management of patients with lymphoma, containing the latest updates on current and emerging therapies across the field
Edited and written by renowned experts in lymphoma research from the City of Hope National Medical Center in California, USA
Engaging images, tables, and treatment algorithms make this a key reference for understanding and treating patients with all types of lymphoma
Includes supplementary material: sn.pub/extras
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (15 chapters)
-
Front Matter
-
Case Study Section One: Indolent B-Cell Lymphomas
-
Front Matter
-
-
Case Study Section Two: Aggressive B-Cell Lymphomas
-
Front Matter
-
-
Case Study Section Three: T-Cell Lymphomas
-
Front Matter
-
-
Case Study Section Four: Hodgkin Lymphoma
-
Front Matter
-
-
Case Study Section Five: Lymphomas in Special Clinical Situations
-
Front Matter
-
About this book
This book will provide an overview of how to manage patients with lymphoma in the format of a series of engaging case studies. Lymphomas are cancers that originate in the lymphatic system. There are two main types of lymphoma: Hodgkin lymphoma and non-Hodgkin lymphoma. These lymphomas comprise various subtypes with prognosis and treatment depending on the stage and type of the cancer. Lymphoma is a major global health problem; non-Hodgkin lymphoma in particular is the tenth most common type of cancer worldwide. In response to this there have been a number of significant advances in the available treatment options for lymphoma with new breakthrough drugs being approved or registered for approval. In light of this, this case study book will be an extremely timely guide for all hematologists, oncologists, and healthcare professionals wishing to keep up-to-date with these recent developments. The format of this book is also particularly appealing as it offer readers a practical approach to the clinical management of patients with these conditions as suggested by leading physicians from the City of Hope National Medical Center in California, USA in an era of vast therapeutic development.
Editors and Affiliations
-
City of Hope Hospital, Duarte, USA
Jasmine Zain
-
Toni Stephenson Lymphoma Center, City of Hope Hospital, Duarte, USA
Larry W. Kwak
About the editors
Larry W Kwak MD, PhD, joined City of Hope as inaugural Cancer Center Associate Director, Translational Research & Developmental Therapeutics in April 2015. Dr Kwak graduated from the 6-year combined BS-MD Honors Program in Medical Education from Northwestern University Medical School in 1982 and earned his PhD in tumor cell biology there in 1984. He then completed a residency in internal medicine and a fellowship in medical oncology at Stanford University Medical Center in California. Thereafter, he served as Head of the Vaccine Biology Section, Experimental Transplantation and Immunology Branch, at the National Cancer Institute (NCI) for 12 years. His NCI laboratory is credited with the pioneering bench-to-clinic development of a therapeutic cancer vaccine for B-cell malignancies, which was recently reported as positive in a landmark national Phase III clinical trial. This was one of three recently positive Phase III clinical trials of cancer vaccine immunotherapy. From 2004–14 Dr Kwak served as Chairman of the Department of Lymphoma and Myeloma and Co-Director of the Center for Cancer Immunology Research at the University of Texas, MD Anderson Cancer Center in Houston, Texas, where he also held the Justin Distinguished Chair in Leukemia Research. As Chair, his department successfully captured extensive research support, including large team science grants, such as two SPORE grants in Lymphoma and Multiple Myeloma, respectively, from the NCI and a SCOR program project grant awarded by the Leukemia and Lymphoma Society. He also led the expansion of the department’s laboratory research space and launched biospecimens banks to support translational research. A committed physician, scientist, and mentor, his vision is to assemble and lead research teams to integrate basic discoveries from academic laboratories with translational clinical development to first-in-human clinical trials of novel ‘homegrown’ therapeutics, such as next generation cancer immunotherapies. He plays a key role in the future direction of City of Hope’s translational and precision medicine and ‘teamwork science’ initiatives. He is an expert in the clinical management of patients with low grade lymphomas. In 2010 Dr Kwak was named to the TIME 100, one of the world’s 100 most influential people by TIME magazine, for his 20 year commitment to the science of cancer immunotherapy. In 2016, he was awarded the Ho-Am Prize in Medicine for his pioneering research in cancer immunotherapy.
Bibliographic Information
Book Title: Management of Lymphomas: A Case-Based Approach
Editors: Jasmine Zain, Larry W. Kwak
DOI: https://doi.org/10.1007/978-3-319-26827-9
Publisher: Adis Cham
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Springer International Publishing AG 2017
Softcover ISBN: 978-3-319-26825-5Published: 10 May 2017
eBook ISBN: 978-3-319-26827-9Published: 28 April 2017
Edition Number: 1
Number of Pages: XXII, 204
Number of Illustrations: 10 b/w illustrations, 26 illustrations in colour
Topics: Hematology, Oncology, Cancer Research, Pharmacotherapy